What is Tissue-Grown?
Headquartered in Santa Paula, California, Tissue-Grown Corporation operates at the intersection of advanced plant science and commercial agriculture. The company specializes in the mass production of disease-indexed horticultural crops, with a primary focus on high-demand commodities such as pistachios, coffee, and walnuts. By leveraging state-of-the-art micropropagation facilities, the firm provides growers with genetically superior, disease-free planting material that enhances crop yield and resilience.
The company's market position is defined by its integration of rigorous scientific research with high-volume production capabilities. Unlike traditional nursery operations, Tissue-Grown utilizes sophisticated cell genetics to ensure uniformity and health across its product lines. This technical edge allows the firm to serve large-scale agricultural enterprises that require consistent, high-quality inputs to mitigate the risks associated with modern climate and pathogen-related challenges in global farming.
How much funding has Tissue-Grown raised?
Tissue-Grown has raised a total of $2M across 3 funding rounds:
Debt
$350K
Debt
$600K
Debt
$1.1M
Debt (2020): $350K with participation from PPP
Debt (2021): $600K led by PPP
Debt (2024): $1.1M, investors not publicly disclosed
Key Investors in Tissue-Grown
PPP
Public-Private Partnership
Undisclosed Investor
A strategic partner participating in the latest funding round to facilitate the expansion of high-volume horticultural production capabilities.
Undisclosed Investor
An undisclosed investor providing capital to support the long-term research and development initiatives in plant genetics and micropropagation.
What's next for Tissue-Grown?
With the successful closure of its latest financing round, Tissue-Grown is poised to enter a phase of aggressive operational expansion. The strategic roadmap focuses on increasing the throughput of its Santa Paula facilities and exploring new partnerships to broaden its reach in the international nut and coffee markets. By prioritizing sustainable propagation practices, the company aims to address the growing global demand for resilient agricultural inputs while maintaining its commitment to genetic integrity.
Future initiatives will likely involve the scaling of its research capabilities to address emerging plant pathogens and the optimization of rootstock performance in diverse climatic conditions. As the company continues to leverage its enterprise-level backing, it remains well-positioned to lead the transition toward more efficient, technology-driven horticultural production systems.
